Cargando…
Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron damage. Due to the complexity of the ALS, so far the etiology and underlying pathogenesis of sporadic ALS are not completely understood. Recently, many studies have emphasized the role of inf...
Autores principales: | Jiang, Zongzhi, Wang, Ziyi, Wei, Xiaojing, Yu, Xue-Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815501/ https://www.ncbi.nlm.nih.gov/pubmed/36618399 http://dx.doi.org/10.3389/fimmu.2022.1059994 |
Ejemplares similares
-
Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications
por: Liu, Jia, et al.
Publicado: (2017) -
Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
por: Toth, Reka P., et al.
Publicado: (2018) -
Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
por: Yang, Xiaoming, et al.
Publicado: (2021) -
Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019) -
Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Moreno-Martínez, Laura, et al.
Publicado: (2019)